Pharma-Bio Serv (OTCMKTS:PBSV) Posts Earnings Results, Misses Expectations By $0.02 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) announced its earnings results on Monday. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02), Zacks reports. Pharma-Bio Serv had a negative net margin of 0.86% and a negative return on equity of 0.66%.

Pharma-Bio Serv Stock Performance

PBSV traded up $0.08 on Monday, hitting $0.57. 3,793 shares of the company were exchanged, compared to its average volume of 5,019. The business’s fifty day moving average is $0.53 and its 200 day moving average is $0.54. Pharma-Bio Serv has a fifty-two week low of $0.43 and a fifty-two week high of $1.36. The firm has a market capitalization of $12.94 million, a P/E ratio of -56.50 and a beta of 0.64.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.